S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Why did Biden repeal Trump's Executive Order?! (Ad)
FuelCell Is Back To Realistic Valuation
New Mexico reaches $500M settlement with Walgreens in opioid case
Why did Biden repeal Trump's Executive Order?! (Ad)
Nigeria's central bank chief arrested after being suspended by president
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Oregon Democratic Party to send federal officials a $500,000 donation from former FTX executive
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Why did Biden repeal Trump's Executive Order?! (Ad)
FuelCell Is Back To Realistic Valuation
New Mexico reaches $500M settlement with Walgreens in opioid case
Why did Biden repeal Trump's Executive Order?! (Ad)
Nigeria's central bank chief arrested after being suspended by president
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Oregon Democratic Party to send federal officials a $500,000 donation from former FTX executive
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Why did Biden repeal Trump's Executive Order?! (Ad)
FuelCell Is Back To Realistic Valuation
New Mexico reaches $500M settlement with Walgreens in opioid case
Why did Biden repeal Trump's Executive Order?! (Ad)
Nigeria's central bank chief arrested after being suspended by president
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Oregon Democratic Party to send federal officials a $500,000 donation from former FTX executive
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
MarketBeat Week in Review – 6/4 - 6/9
Why did Biden repeal Trump's Executive Order?! (Ad)
FuelCell Is Back To Realistic Valuation
New Mexico reaches $500M settlement with Walgreens in opioid case
Why did Biden repeal Trump's Executive Order?! (Ad)
Nigeria's central bank chief arrested after being suspended by president
American Airlines, JetBlue seek to keep some ties despite losing antitrust case
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Oregon Democratic Party to send federal officials a $500,000 donation from former FTX executive
Ukrainian President Volodymyr Zelenskyy says ‘counteroffensive, defensive actions’ taking place in war with Russia
Positive News SentimentPositive News
NASDAQ:PETS

PetMed Express (PETS) Earnings Date, Estimates & Call Transcripts

$14.96
-0.26 (-1.71%)
(As of 06/9/2023 ET)
Compare
Today's Range
$14.95
▼
$15.49
50-Day Range
$14.61
▼
$16.56
52-Week Range
$14.05
▼
$24.01
Volume
491,885 shs
Average Volume
467,354 shs
Market Capitalization
$316.70 million
P/E Ratio
748.37
Dividend Yield
8.02%
Price Target
$18.50
ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Jul. 24Estimated
Actual EPS
(May. 22)
-$0.25 Missed By -$0.39
Consensus EPS
(May. 22)
$0.14
Last Year's Q2 EPS
(5/9/2022)
$0.30
Read Call Transcript
Listen to Call
Latest SEC 10-Q Filing
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

PETS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PETS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

PetMed Express Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20231$0.30$0.30$0.30
Q2 20231$0.23$0.23$0.23
Q3 20231$0.20$0.20$0.20
Q4 20231$0.12$0.12$0.12
FY 20234$0.85$0.85$0.85
Q1 20241$0.22$0.22$0.22
Q2 20241$0.20$0.20$0.20
Q3 20241$0.13$0.13$0.13
Q4 20241$0.19$0.19$0.19
FY 20244$0.74$0.74$0.74

PETS Earnings Date and Information

PetMed Express last posted its quarterly earnings results on May 22nd, 2023. The reported ($0.25) earnings per share for the quarter, missing the consensus estimate of $0.14 by $0.39. The business had revenue of $62.41 million for the quarter, compared to the consensus estimate of $69.93 million. PetMed Express has generated $0.02 earnings per share over the last year ($0.02 diluted earnings per share) and currently has a price-to-earnings ratio of 748.4. Earnings for PetMed Express are expected to grow by 10.91% in the coming year, from $0.55 to $0.61 per share. PetMed Express has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, July 24th, 2023 based off prior year's report dates.

PetMed Express Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
7/24/2023
(Estimated)		        
5/22/20233/31/2023$0.14($0.25)($0.39)$0.33$69.93 million$62.41 million      
2/6/2023Q3 2023$0.21$0.02($0.19)$0.04$63.71 million$58.87 million
11/7/2022Q2 2023$0.27$0.13($0.14)$0.13$65.00 million$65.39 million
7/25/2022Q1 2023$0.26$0.14($0.12)$0.14$80.70 million$70.19 million    
5/9/2022Q4 2022$0.27$0.30+$0.03$0.30$67.80 million$66.00 million    
1/24/2022Q3 2022$0.30$0.21($0.09)$0.21$61.90 million$60.72 million    
10/24/20219/30/2021$0.34$0.31($0.03)$0.31$70.90 million$67.39 million    
7/25/20216/30/2021$0.38$0.26($0.12)$0.30$79.31 million  
5/2/20213/31/2021$0.40$0.34($0.06)$0.34$74.04 million$71.70 million  
1/18/202112/31/2020$0.38$0.38$0.38$63.81 million$65.90 million  
10/31/20209/30/2020$0.40$0.42+$0.02$0.42$77.05 million$75.40 million  
7/20/20206/30/2020$0.40$0.39($0.01)$0.39$90.96 million$96.20 million  
5/4/20203/31/2020$0.29$0.35+$0.06$0.35$66.24 million$74.30 million  
1/21/2020Q3 20$0.30$0.34+$0.04$0.34$61.31 million$59.92 million  
10/21/2019Q2$0.26$0.33+$0.07$0.33$69.65 million$69.94 million  
7/22/2019Q1$0.42$0.26($0.16)$0.26$85.83 million$79.99 million  
5/6/20193/31/2019$0.46$0.32($0.14)$0.32$69.06 million$64.57 million  
1/22/201912/31/2018$0.48$0.38($0.10)$0.38$64.22 million$60.10 million  
10/22/20189/30/2018$0.50$0.52+$0.02$0.52$71.93 million$71.40 million  
7/23/2018Q1 2019$0.63$0.62($0.01)$0.62$85.72 million$87.39 million
5/7/2018Q4$0.47$0.50+$0.03$0.50$68.43 million$67.30 million
1/22/2018Q3 2018$0.33$0.44+$0.11$0.44$56.76 million$60.10 million  
10/23/2017Q2 2018$0.30$0.43+$0.13$0.43$63.41 million$66.70 million
7/24/2017Q1 2018$0.38$0.45+$0.07$0.45$77.32 million$79.66 million
5/8/2017Q4 17$0.26$0.37+$0.11$0.37$56.53 million$63.03 million  
1/23/2017Q3 2017$0.25$0.24($0.01)$0.24$52.70 million$52.90 million
10/24/2016Q2 2017$0.26$0.24($0.02)$0.24$58.47 million$60.80 million
7/25/2016Q1 2017$0.30$0.32+$0.02$0.32$72.90 million$72.49 million
5/9/2016Q4 2016$0.24$0.27+$0.03$0.27$50.20 million$55.40 million
1/25/2016Q3 2016$0.24$0.24$0.24$49.28 million$50.90 million  
10/19/2015Q2 2016$0.20$0.22+$0.02$0.22$58.34 million$56.70 million  
7/20/2015Q1 2016$0.28$0.29+$0.01$0.29$73.04 million$71.60 million
5/4/2015Q4 2015$0.24$0.25+$0.01$0.25$49.11 million$50.00 million
1/20/2015Q3 2015$0.25$0.24($0.01)$0.24$49.26 million$49.30 million
10/20/2014Q2 2015$0.21$0.19($0.02)$0.24$61.22 million$57.60 million  
7/21/2014Q1 2015$0.25$0.25$0.25$74.25 million$72.50 million
5/5/2014Q4 2014$0.21$0.23+$0.02$0.23$55.02 million$48.60 million
1/21/2014Q3 2014$0.23$0.23$0.23$52.06 million$50.10 million
10/21/2013Q2 2014$0.22$0.21($0.01)$0.21$60.33 million$80.50 million  
7/22/2013Q1 2014$0.22$0.24+$0.02$0.24$69.55 million$74.20 million  
5/6/2013Q4 2013$0.21$0.23+$0.02$0.23$55.31 million$51.10 million
1/22/2013Q3 2012$0.17$0.23+$0.06$49.97 million$49.60 million
10/22/2012$0.17$0.20+$0.03
7/23/2012$0.23$0.20($0.03)
5/7/2012$0.18$0.20+$0.02
1/23/2012$0.16$0.19+$0.03
10/24/2011$0.15$0.19+$0.04
7/18/2011$0.24$0.22($0.02)
5/9/2011$0.23$0.19($0.04)  
1/24/2011$0.20$0.20  
10/18/2010Q2 2011$0.26$0.22($0.04)$0.22
7/19/2010Q1 2011$0.38$0.32($0.06)$0.32
5/10/2010Q4 2010$0.27$0.27$0.27
1/19/2010Q3 2010$0.23$0.25+$0.02$0.25
10/19/2009Q2 2010$0.28$0.28$0.28
7/20/2009Q1 2010$0.31$0.36+$0.05$0.36
5/11/2009Q4 2009$0.22$0.25+$0.03$0.25
1/20/2009Q3 2009$0.20$0.21+$0.01$0.21
10/20/2008Q2 2009$0.20$0.25+$0.05$0.25
7/21/2008Q1 2009$0.27$0.28+$0.01$0.28
5/12/2008Q4 2008$0.18$0.20+$0.02$0.20
1/22/2008Q3 2008$0.14$0.18+$0.04$0.18












PetMed Express Earnings - Frequently Asked Questions

When is PetMed Express's earnings date?

PetMed Express has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, July 24th, 2023 based off last year's report dates. Learn more on PETS's earnings history.

Did PetMed Express beat their earnings estimates last quarter?

In the previous quarter, PetMed Express (NASDAQ:PETS) missed the analysts' consensus estimate of $0.14 by $0.39 with a reported earnings per share (EPS) of ($0.25). Learn more on analysts' earnings estimate vs. PETS's actual earnings.

How can I listen to PetMed Express's earnings conference call?

The conference call for PetMed Express's latest earnings report can be listened to online. Listen to Conference Call

How can I read PetMed Express's conference call transcript?

The conference call transcript for PetMed Express's latest earnings report can be read online. Read Transcript

How can I view PetMed Express's earnings report?

PetMed Express's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does PetMed Express generate each year?

PetMed Express (NASDAQ:PETS) has a recorded annual revenue of $256.86 million.

How much profit does PetMed Express generate each year?

PetMed Express (NASDAQ:PETS) has a recorded net income of $230,000.00. PETS has generated $0.02 earnings per share over the last four quarters.

What is PetMed Express's price-to-earnings ratio?

PetMed Express (NASDAQ:PETS) has a trailing price-to-earnings ratio of 748.37 and a forward price-to-earnings ratio of 27.20.

What is PetMed Express's EPS forecast for next year?

PetMed Express's earnings are expected to grow from $0.55 per share to $0.61 per share in the next year, which is a 10.91% increase.

More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:PETS) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -